We assessed the efficacy of an inactivated hepatitis B vaccine in a placebo-controlled, randomized, double-blind trial in 1083 homosexual men known to be at high risk for hepatitis B virus infection. The vaccine was found to be safe and the incidence of side effects was low. Within two months, 77% of the vaccinated persons had high levels of antibody against the hepatitis B surface antigen. This rate increased to 96% after the booster dose and remained essentially unchanged for the duration of the trial. For the first 18 months of follow-up, hepatitis B or subclinical infection developed in only 1.4 to 3.4% of the vaccine recipients as compared with 18 to 27% of placebo recipients (P < 0.0001). The reduction of incidence in the vaccinees was as high as 92.3%; none of the vaccinees with a detectable immune response to the vaccine had clinical hepatitis B or asymptomatic antigenemia. A significant reduction of incidence was already seen within 75 days after randomization; this observation suggests that the vaccine may be efficacious even when given after exposure.
This article has been cited by other articles:
Beasley, R. P.
(2009). Development of Hepatitis B Vaccine. JAMA
302: 322-324
[Full Text]
Sapru, A., Kulkarni, P. S., Bhave, S., Bavdekar, A., Naik, S. S., Pandit, A. N.
(2007). Immunogenicity and Reactogenicity of Two Recombinant Hepatitis B Vaccines in Small Infants: A Randomized, Double-Blind Comparative Study. J Trop Pediatr
53: 303-307
[Abstract][Full Text]
Aggarwal, R., Ranjan, P.
(2004). Preventing and treating hepatitis B infection. BMJ
329: 1080-1086
[Full Text]
Kong, Q., Richter, L., Yang, Y. F., Arntzen, C. J., Mason, H. S., Thanavala, Y.
(2001). Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA
10.1073/pnas.191617598v1
[Abstract][Full Text]
Mahoney, F. J.
(1999). Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection. Clin. Microbiol. Rev.
12: 351-366
[Abstract][Full Text]
Lemon, S. M., Thomas, D. L.
(1997). Vaccines to Prevent Viral Hepatitis. NEJM
336: 196-204
[Full Text]
Bock, H. L., Kruppenbacher, J., Sanger, R., Hobel, W., Clemens, R., Jilg, W.
(1996). Immunogenicity of a Recombinant Hepatitis B Vaccine in Adults. Arch Intern Med
156: 2226-2231
[Abstract]
Francis, D. P.
(1995). The Public's Health Unprotected: Reversing a Decade of Underutilization of Hepatitis B Vaccine. JAMA
274: 1242-1243
[Abstract]
Wood, D. L., Rosenthal, P., Scarlata, D.
(1995). California Pediatricians' Knowledge of and Response to Recommendations for Universal Infant Hepatitis B Immunization. Arch Pediatr Adolesc Med
149: 769-773
[Abstract]
Cleveland, J.L., Siew, C., Lockwood, S.A., Gruninger, S.E., Chang, S.-B., Neidle, E.A., Russell, C.M.
(1994). Factors Associated with Hepatitis B Vaccine Response Among Dentists. JDR
73: 1029-1035
[Abstract]
Tan, K. L., Goh, K. T., Oon, C. J., Chan, S. H.
(1994). Immunogenicity of Recombinant Yeast-Derived Hepatitis B Vaccine in Nonresponders to Perinatal Immunization. JAMA
271: 859-861
[Abstract]
Wood, R. C., MacDonald, K. L., White, K. E., Hedberg, C. W., Hanson, M., Osterholm, M. T.
(1993). Risk Factors for Lack of Detectable Antibody Following Hepatitis B Vaccination of Minnesota Health Care Workers. JAMA
270: 2935-2939
[Abstract]
Krahn, M., Detsky, A. S.
(1993). Should Canada and the United States Universally Vaccinate Infants against Hepatitis B?: A Cost - Effectiveness Analysis. Med Decis Making
13: 4-20
[Abstract]
Silverman, N. S., Darby, M. J., Ronkin, S. L., Wapner, R. J.
(1991). Hepatitis B Prevalence in an Unregistered Prenatal Population: Implications for Neonatal Therapy. JAMA
266: 2852-2855
[Abstract]
Kuvin, J. T.
(1990). The Prevention of Hepatitis B in Medical Students. JAMA
264: 1104-1105
[Abstract]
Perez-Romero, M., Sanchez-Quijano, A., Lissen, E.
(1990). Transmission of Hepatitis C Virus. ANN INTERN MED
113: 411-412
[Abstract]
Kingsley, L. A., Rinaldo, C. R. Jr, Lyter, D. W., Valdiserri, R. O., Belle, S. H., Ho, M.
(1990). Sexual Transmission Efficiency of Hepatitis B Virus and Human Immunodeficiency Virus Among Homosexual Men. JAMA
264: 230-234
[Abstract]
Halliday, M. L., Rankin, J. G., Bristow, N. J., Coates, R. A., Corey, P. N. J., Strickler, A. C.
(1990). A Randomized Double-blind Clinical Trial of a Mammalian Cell-Derived Recombinant DNA Hepatitis B Vaccine Compared With a Plasma-Derived Vaccine. Arch Intern Med
150: 1195-1200
[Abstract]
Alter, M. J., Coleman, P. J., Alexander, W. J., Kramer, E., Miller, J. K., Mandel, E., Hadler, S. C., Margolis, H. S.
(1989). Importance of Heterosexual Activity in the Transmission of Hepatitis B and Non-A, Non-B Hepatitis. JAMA
262: 1201-1205
[Abstract]
Hicks, R. A., Cullen, J. W., Jackson, M. A., Burry, V. F.
(1989). Hepatitis B Virus Vaccine: Cost-Benefit Analysis of its Use in a Children's Hospital. CLIN PEDIATR
28: 359-365
[Abstract]
Francis, D. P., Margolis, H. S.
(1989). Worldwide Elimination of Hepatitis B Transmission: We Have the Way, We Need the Will. JAMA
261: 2400-2401
[Abstract]
Kuo, G, Choo, Q., Alter, H., Gitnick, G., Redeker, A., Purcell, R., Miyamura, T, Dienstag, J., Alter, M., Stevens, C., et, al.
(1989). An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science
244: 362-364
[Abstract]
Fauci, A. S., Gallo, R. C., Koenig, S., Salk, J., Purcell, R. H.
(1989). Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection. ANN INTERN MED
110: 373-385
[Abstract]
Reese, C. E., Ockner, R. K.
(1989). Prevention of Hepatitis B in Surgeons and Their Patients. PERSPECT VASC SURG ENDOVASC THER
2: 138-147
Stoneburner, R., Des Jarlais, D., Benezra, D, Gorelkin, L, Sotheran, J., Friedman, SR, Schultz, S, Marmor, M, Mildvan, D, Maslansky, R
(1988). A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science
242: 916-919
[Abstract]
Hadler, S. C.
(1988). Hepatitis B Prevention and Human Immunodeficiency Virus (HIV) Infection. ANN INTERN MED
109: 92-94
[Abstract]
Collier, A. C., Corey, L., Murphy, V. L., Handsfield, H. H.
(1988). Antibody to Human Immunodeficiency Virus (HIV) and Suboptimal Response to Hepatitis B Vaccination. ANN INTERN MED
109: 101-105
[Abstract]
HOROWITZ, M. M., ERSHLER, W. B., MCKINNEY, W. P., BATTIOLA, R. J.
(1988). Duration of Immunity After Hepatitis B Vaccination: Efficacy of Low-Dose Booster Vaccine. ANN INTERN MED
108: 185-189
[Abstract]
(1987). Update on Hepatitis B Prevention: Recommendations of the Immunization Practices Advisory Committee. ANN INTERN MED
107: 353-357
[Abstract]
(1987). Leads From the MMWR. JAMA
258: 437-449
Hollinger, F. B.
(1987). Hepatitis B Vaccines--to Switch or Not to Switch. JAMA
257: 2634-2636
[Abstract]
LaForce, F. M.
(1987). Immunizations, Immunoprophylaxis, and Chemoprophylaxis to Prevent Selected Infections. JAMA
257: 2464-2470
[Abstract]
CRAVEN, D. E., AWDEH, Z. L., KUNCHES, L. M., YUNIS, E. J., DIENSTAG, J. L., WERNER, B. G., POLK, B. F., SNYDMAN, D. R., PLATT, R., CRUMPACKER, C. S., GRADY, G. F., ALPER, C. A.
(1986). Nonresponsiveness to Hepatitis B Vaccine in Health Care Workers: Results of Revaccination and Genetic Typings. ANN INTERN MED
105: 356-360
[Abstract]
Francis, D. P., Feorino, P. M., McDougal, S., Warfield, D., Getchell, J., Cabradilla, C., Tong, M., Miller, W. J., Schultz, L. D., Bailey, F. J., McAleer, W. J., Scolnick, E. M., Ellis, R. W.
(1986). The Safety of the Hepatitis B Vaccine: Inactivation of the AIDS Virus During Routine Vaccine Manufacture. JAMA
256: 869-872
[Abstract]
Stevens, C. E., Taylor, P. E., Zang, E. A., Morrison, J. M., Harley, E. J., de Cordoba, S. R., Bacino, C., Ting, R. C. Y., Bodner, A. J., Sarngadharan, M. G., Gallo, R. C., Rubinstein, P.
(1986). Human T-Cell Lymphotropic Virus Type III Infection in a Cohort of Homosexual Men in New York City. JAMA
255: 2167-2172
[Abstract]
Weber, D. J., Rutala, W. A., Samsa, G. P., Santimaw, J. E., Lemon, S. M.
(1985). Obesity as a Predictor of Poor Antibody Response to Hepatitis B Plasma Vaccine. JAMA
254: 3187-3189
[Abstract]
Alter, M. J., Favero, M. S., Maynard, J. E.
(1985). Hepatitis B Vaccine Use in Chronic Hemodialysis Centers in the United States. JAMA
254: 3200-3202
[Abstract]
Redfield, R. R., Innis, B. L., Scott, R. M., Cannon, H. G., Bancroft, W. H.
(1985). Clinical Evaluation of Low-Dose Intradermally Administered Hepatitis B Virus Vaccine: A Cost Reduction Strategy. JAMA
254: 3203-3206
[Abstract]
Valenzuela, T. D., Hook, E. W. III, Copass, M. K., Corey, L.
(1985). Occupational Exposure to Hepatitis B in Paramedics. Arch Intern Med
145: 1976-1977
[Abstract]
Remafedi, G. J.
(1985). Adolescent Homosexuality: Issues for Pediatricians. CLIN PEDIATR
24: 481-485
[Abstract]
(1985). Recommendations for Protection Against Viral Hepatitis: Recommendation of the Immunization Practices Advisory Committee. ANN INTERN MED
103: 391-402
[Abstract]
Dienstag, J. L., Werner, B. G., McLane, M. F., Snydman, D. R., Grady, G. F., Craven, D. E., Crumpacker, C. S., Polk, B. F., Platt, R., Allan, J., Essex, M.
(1985). Absence of Antibodies to HTLV-III in Health Workers After Hepatitis B Vaccination. JAMA
254: 1064-1066
[Abstract]
WERNER, B. G., DIENSTAG, J. L., KUTER, B. J., POLK, B. F., SNYDMAN, D. R., CRAVEN, D. E., CRUMPACKER, C. S., PLATT, R., GRADY, G. F.
(1985). Isolated Antibody to Hepatitis B Surface Antigen and Response to Hepatitis B Vaccination. ANN INTERN MED
103: 201-205
[Abstract]
(1985). Leads from the MMWR. JAMA
254: 197-217
PATTERSON, W. B., CRAVEN, D. E., SCHWARTZ, D. A., NARDELL, E. A., KASMER, J., NOBLE, J.
(1985). Occupational Hazards to Hospital Personnel. ANN INTERN MED
102: 658-680
[Abstract]
(1985). Leads from the MMWR. JAMA
253: 1705-1707
BLUMBERG, B. S., FOX, R. C.
(1985). The Daedalus Effect: Changes in Ethical Questions Relating to Hepatitis B Virus. ANN INTERN MED
102: 390-394
[Abstract]
Lelie, P. N., Reesink, H. W., de Jong-van Manen, S. Th., Dees, P. J., Reerink-Brongers, E. E.
(1985). Immune Response to a Heat-Inactivated Hepatitis B Vaccine in Patients Undergoing Hemodialysis: Enhancement of the Response by Increasing the Dose of Hepatitis B Surface Antigen From 3 to 27 {micro}g. Arch Intern Med
145: 305-309
[Abstract]
Sacks, H. S., Rose, D. N., Chalmers, T. C.
(1984). Should the Risk of Acquired Immunodeficiency Syndrome Deter Hepatitis B Vaccination? A Decision Analysis. JAMA
252: 3375-3377
[Abstract]
Harris, J. R., Finger, R. F., Kobayashi, J. M., Hadler, S. C., Murphy, B. L., Berkelman, R. L., Bussell, K. E.
(1984). The Low Risk of Hepatitis B in Rural Hospitals: Results of a Seroepidemiologic Survey. JAMA
252: 3270-3272
[Abstract]
McLeod, B. C., Scott, J. P.
(1984). Use of 'Single Donor' Factor VIII From Plasma Exchange Donation. JAMA
252: 2726-2729
[Abstract]
DIENSTAG, J. L., WERNER, B. G., POLK, B. F., SNYDMAN, D. R., CRAVEN, D. E., PLATT, R., CRUMPACKER, C. S., OUELLET-HELLSTROM, R., GRADY, G. F.
(1984). Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy. ANN INTERN MED
101: 34-40
[Abstract]
Kennedy, R., Melnick, J., Dreesman, G.
(1984). Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. Science
223: 930-931
[Abstract]
HADLER, S. C., DE MONZON, M., PONZETTO, A., ANZOLA, E., RIVERO, D., MONDOLFI, A., BRACHO, A., FRANCIS, D. P., GERBER, M. A., THUNG, S., GERIN, J., MAYNARD, J. E., POPPER, H., PURCELL, R. H.
(1984). Delta Virus Infection and Severe Hepatitis: An Epidemic in the Yucpa Indians of Venezuela. ANN INTERN MED
100: 339-344
[Abstract]
PERRILLO, R. P., CAMPBELL, C. R., SANDERS, G. E., REGENSTEIN, F. G., BODICKY, C. J.
(1984). Spontaneous Clearance and Reactivation of Hepatitis B Virus Infection Among Male Homosexuals with Chronic Type B Hepatitis. ANN INTERN MED
100: 43-46
[Abstract]
HEALTH AND PUBLIC POLICY COMMITTEE,
(1984). Hepatitis B Vaccine. ANN INTERN MED
100: 149-150
[Abstract]
Hamilton, J. D.
(1983). Hepatitis B Virus Vaccine: An Analysis of Its Potential Use in Medical Workers. JAMA
250: 2145-2150
[Abstract]
Francis, D. P.
(1983). Hepatitis B Virus Vaccine An Opportunity for Control. JAMA
250: 1891-1892
[Abstract]
MINTZ, L., DREW, W. L., MINER, R. C., BRAFF, E. H.
(1983). Cytomegalovirus Infections in Homosexual Men: An Epidemiological Study. ANN INTERN MED
99: 326-329
[Abstract]
Gerety, R. J., Tabor, E.
(1983). Newly Licensed Hepatitis B Vaccine: Known Safety and Unknown Risks. JAMA
249: 745-746
[Abstract]
(1982). Infectious Diseases: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers. ANN INTERN MED
97: 938-943
[Abstract]
Kohler, P. F., Brown, W. R.
(1982). Immunologic Aspects of Hepatic and Gastrointestinal Tract Disease. JAMA
248: 2704-2709
[Abstract]
Payne, J. A.
(1982). Viral Hepatitis. Arch Dermatol
118: 945-948
[Abstract]
POLESKI, M. H.
(1982). Kaposi's Sarcoma and Hepatitis B Vaccine. ANN INTERN MED
97: 786-787
[Abstract]
FRANCIS, D. P., HADLER, S. C., THOMPSON, S. E., MAYNARD, J. E., OSTROW, D. G., ALTMAN, N., BRAFF, E. H., O'MALLEY, P., HAWKINS, D., JUDSON, F. N., PENLEY, K., NYLUND, T., CHRISTIE, G., MEYERS, F., MOORE, J. N. Jr, GARDNER, A., DOTO, I. L., MILLER, J. H., REYNOLDS, G. H., MURPHY, B. L., SCHABLE, C. A., CLARK, B. T., CURRAN, J. W., REDEKER, A. G.
(1982). The Prevention of Hepatitis B with Vaccine: Report of the Centers for Disease Control Multi-Center Efficacy Trial Among Homosexual Men. ANN INTERN MED
97: 362-366
[Abstract]
(1982). Inactivated Hepatitis B Virus Vaccine: Recommendation of the Immunization Practices Advisory Committee. ANN INTERN MED
97: 379-383
[Abstract]
MAYNARD, J. E.
(1982). Prevention of Hepatitis B Through the Use of Vaccine. ANN INTERN MED
97: 442-444
[Abstract]
DIENSTAG, J. L., STEVENS, C. E., BHAN, A. K., SZMUNESS, W.
(1982). Hepatitis B Vaccine Administered to Chronic Carriers of Hepatitis B Surface Antigen. ANN INTERN MED
96: 575-579
[Abstract]
King, J. W.
(1982). A Clinical Approach to Hepatitis B. Arch Intern Med
142: 925-928
[Abstract]
Alter, H. J.
(1982). The Evolution, Implications, and Applications of the Hepatitis B Vaccine. JAMA
247: 2272-2275
[Abstract]
Iber, F. L.
(1982). Carrier Status in Hepatitis B: A Modern Scourge With Hope. JAMA
247: 2275-2276
[Abstract]
Krugman, S.
(1982). The Newly Licensed Hepatitis B Vaccine: Characteristics and Indications for Use. JAMA
247: 2012-2015
[Abstract]
Koplan, J. P., Kane, M. A.
(1982). Management of Needle-Stick Exposures. Med Decis Making
2: 129-131
GERETY, R. J.
(1981). Hepatitis B Transmission Between Dental or Medical Workers and Patients. ANN INTERN MED
95: 229-231
[Abstract]
Tiollais, P, Charnay, P, Vyas, G.
(1981). Biology of hepatitis B virus. Science
213: 406-411
[Abstract]
Sabin, A. B.
(1981). Immunization: Evaluation of Some Currently Available and Prospective Vaccines. JAMA
246: 236-241
[Abstract]
Hussey, H. H.
(1981). The Hepatitis B Saga. JAMA
245: 1317-1318
[Abstract]
PERKINS, H. S., JONSEN, A. R.
(1981). Conflicting Duties to Patients: The Case of a Sexually Active Hepatitis B Carrier. ANN INTERN MED
94: 523-530
[Abstract]
Kong, Q., Richter, L., Yang, Y. F., Arntzen, C. J., Mason, H. S., Thanavala, Y.
(2001). Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA
98: 11539-11544
[Abstract][Full Text]
